LMAT

LMAT

USD

LeMaitre Vascular Inc. Common Stock

$86.820+3.820 (4.602%)

实时价格

Healthcare
Medical Instruments & Supplies
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$83.000

最高价

$89.010

最低价

$81.570

成交量

0.06M

公司基本面

市值

2.0B

所属行业

Medical Instruments & Supplies

国家/地区

United States

交易统计

平均成交量

0.17M

交易所

NGM

货币

USD

52周价格范围

最低价 $71.42当前价 $86.820最高价 $109.58

AI分析报告

最后更新: 2025年10月30日
由AI生成数据来源: Yahoo Finance, Bloomberg, SEC

LMAT Analysis: LeMaitre Vascular Faces Key Inflection Point Ahead of Earnings

Price Action: Volatility and Support Testing

LeMaitre Vascular (LMAT) has experienced a rollercoaster ride over the past three months. The stock surged from $81 to $93.04 in early August (+15%) but later dropped to $84.66 in late September (-9%), only to stabilize near $88.55 as of October 30. Key patterns to note:

  • Support Zone Alert: The stock hovers near $89.16, a critical support level. Recent lows on October 29 ($88.33) and October 30 ($87.82) suggest sellers are testing this level.
  • Volume Contrasts: Surge days (August 6: +18%, volume 428,600) contrast sharply with the 509,700 volume crash on August 26 (-5%), indicating emotional retail trader involvement.
  • Technical Tug-of-War: Mixed signals - the MACD "death cross" warns of bearish momentum, while the OBV spike on October 30 shows sudden buying pressure.

Sentiment: Analysts Push Against Market Skepticism

  • Positive Catalyst: Barrington Research reiterated its $95 price target on October 15, implying 7.2% upside from current levels. 8 analysts collectively project a $104.62 average target (+17.9% potential).
  • Earnings Countdown: The company’s Q3 results (November 6) create a natural inflection point. Historical volatility around reporting dates could amplify moves post-announcement.
  • Market Disconnect: Despite the analyst optimism, the stock underperforms its 52-week high ($109.58) by 19% and trades below its P/E ratio of 40.81, which the model flags as "neutral" (not overvalued nor undervalued).

Predictive Outlook: AI Detects Short-Term Momentum

AI models project a cautious upside over 3 days:

  • Day 1: +0.2% (flat move, low confidence)
  • Day 2: +2.6% (strongest signal)
  • Day 3: +2.3% (sustained momentum) Combined with the $91.57 AI target, this suggests potential rebound energy if support at $89.16 holds. However, the technical DMI (-DI 12.5 vs. +DI 8.8) warns of unresolved bearish pressure.

Strategic Guidance: Play the Range, Watch Debt Shadows

Entry Opportunities: If volume surges above 150,000, consider nibbling at shares near the support cluster ($89.09-$90.30). The technical setup favors a bounce, but the high debt-to-equity ratio (51.

相关新闻

Analyst Upgrades

Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $95 Price Target

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular with a Outperform and maintains $95 price target.

查看更多
Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $95 Price Target
GlobeNewswire

LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025

BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market

查看更多
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025

AI预测Beta

AI建议

看涨

更新于: 2025年11月10日 10:37

看跌中性看涨

63.1% 置信度

风险与交易

风险等级3/5
中风险
适合于
适中
交易指南

入场点

$86.47

止盈点

$88.43

止损点

$78.02

关键因素

DMI显示看跌趋势(ADX:6.4,+DI:22.2,-DI:22.5),表明需谨慎
当前价格非常接近支撑水平$86.60,表明有强烈的买入机会
交易量是平均值的9.9倍(2,018),表明极强的买入压力
MACD 0.0663低于信号线0.0715,表明看跌交叉

保持更新

设置价格提醒,获取AI分析更新和实时市场新闻。